Discover Wellness Solutions (WLNS:CSE) believes in approaching the production of marijuana and cannabis products uniquely. Our management team brings expertise in all areas of the operation – where traditional cannabis companies have growers, Discover Wellness Solutions has scientists; where traditional cannabis companies prioritize sales experience, Discover Wellness Solutions prioritizes strategists with strong business acumen and business development experience.
In October 2019, Health Canada issued our wholly owned subsidiary a full license to cultivate, produce, process and sell cannabis in various forms under the Cannabis Act (Canada). Our vision is to build a low cost, highly efficient, hemp processing and CBD extraction business focused on serving a premier set of customers in Canada and abroad.
Discover Wellness Solutions processes hemp and extracts high quality, high consistency CBD from proprietary strains. It’s becoming a leading low cost, wholesale product provider to commercial cannabis businesses.
Discover Wellness Solutions (WLNS:CSE) operates an industrial-scale hemp processing facility in Alberta, Canada and is partnered with industry leading plant genetics firm SynerGenetics Biosciences.
SynerGenetics develops and cultivates proprietary hemp strains which contain higher-CBD, lower-THC content. These strains are more economic to process relative to other strains in the industry giving us an advantage over our peers. This partnership immediately positions WLNS as a low-cost, vertically-integrated cannabis company and as a potential leader in the industry
The WLNS Advantage:
LOW-COST, VERTICALLY INTEGRATED PLATFORM
With our SynerGenetics partnership locked-in, WLNS has full seed-to-sale capability and multi-million pound capacity. We are now focused on becoming the lowest cost producer of CBD concentrates and flower for a rapidly expanding global market.
PROPRIETARY GENETICS & EXCLUSIVE PREMIUM STRAINS
WLNS has exclusive rights to the current and future pipeline of SynerGenetics’ proven high-CBD hemp strains. These proprietary strains contain up to 15%+ CBD content and less than 0.3% THC – one of the highest ratios in the industry. Currently, there is a pipeline of over 20 new strains in development.
MAJOR GROWTH POTENTIAL
Our industrial-scale hemp processing and CBD extraction facility has a current footprint of 23,400 square feet in size and is expandable to over 100,000 square feet equivalent – 4-fold growth potential.
Discover Wellness Solutions (WLNS:CSE) is focused on becoming the lowest cost producer of high-quality, high consistency CBD concentrates.
Our industrial-scale CBD extraction and processing facility in Alberta, Canada is fully-licensed and highly-scalable for future expansion.
We have also partnered with leading plant genetics and cultivation firm SynerGenetics Biosciences. This partnership gives us exclusive rights to proprietary high-CBD, low-THC strains and has supplied us with 550,000 pounds of high-CBD hemp to date (with more to come).
SynerGenetics Bioscience is a leading plant research and genetics firm focused on the development of high-CBD, low-THC hemp. The company has utilized cutting-edge technology to produce proprietary strains with 15%+ CBD content and less than 0.3% THC – one of the highest ratios in the industry and a key factor that will enable WLNS to produce high quality, high consistency CBD concentrate at lower costs than our competitors.
FN Media Group LLC (FNMG) owns and operates FinancialNewsMedia.com (FNM) which is a third party publisher that disseminates electronic information through multiple online media channels. FNMG’s intended purposes are to deliver market updates and news alerts issued from private and publicly trading companies as well as providing coverage and increased awareness for companies that issue press to the public via online newswires. FNMG and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. The companies that are discussed in this release may or may not have approved the statements made in this release. Information in this release is derived from a variety of sources that may or may not include the referenced company’s publicly disseminated information. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. While this information is believed to be reliable, such reliability cannot be guaranteed. FNMG disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. This release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. This release is not without bias, and is considered a conflict of interest if compensation has been received by FNMG for its dissemination. To comply with Section 17(b) of the Securities Act of 1933, FNMG shall always disclose any compensation it has received, or expects to receive in the future, for the dissemination of the information found herein on behalf of one or more of the companies mentioned in this release. For current services performed FNMG has been compensated forty five hundred dollars for Discover Wellness Solutions Inc. current news coverage by a non-affiliated third party. FNMG HOLDS NO SHARES OF Discover Wellness Solutions Inc.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.